190 related articles for article (PubMed ID: 38027182)
1. The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia.
Rao X; Xu Z; Zhang J; Zhou J; Huang J; Toh Z; Zheng R; Zhou Z
Front Endocrinol (Lausanne); 2023; 14():1290639. PubMed ID: 38027182
[TBL] [Abstract][Full Text] [Related]
2. Causal Associations Between Lifestyle Habits and Risk of Benign Prostatic Hyperplasia: A Two-Sample Mendelian Randomization Study.
Jia F; Wei Z; Kong X; Mao Y; Yang Y
J Gerontol A Biol Sci Med Sci; 2024 Jan; 79(1):. PubMed ID: 37526403
[TBL] [Abstract][Full Text] [Related]
3. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study.
Wang YB; Yang L; Deng YQ; Yan SY; Luo LS; Chen P; Zeng XT
J Transl Med; 2022 Oct; 20(1):495. PubMed ID: 36309747
[TBL] [Abstract][Full Text] [Related]
4. Association between gut microbiota and benign prostatic hyperplasia: a two-sample mendelian randomization study.
Xia D; Wang J; Zhao X; Shen T; Ling L; Liang Y
Front Cell Infect Microbiol; 2023; 13():1248381. PubMed ID: 37799337
[TBL] [Abstract][Full Text] [Related]
5. The causal effect of metabolic syndrome and its components on benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study.
Lv K; Yang G; Wu Y; Xia X; Hao X; Pang A; Han D; Yuan Q; Song T
Prostate; 2023 Oct; 83(14):1358-1364. PubMed ID: 37455410
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte Telomere Length and the Risk of Prostate Cancer and Benign Prostatic Hyperplasia: Insights From UK Biobank and Mendelian Randomization Study.
Lv K; Wu Y; Yang G; Hao X; Huang S; Song T; Yuan Q
J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 38085929
[TBL] [Abstract][Full Text] [Related]
7. Causal relationship between sarcopenia and osteoarthritis: a bi-directional two-sample mendelian randomized study.
Yang J; Liu P; Wang S; Jiang T; Zhang Y; Liu W
Eur J Med Res; 2023 Sep; 28(1):327. PubMed ID: 37689698
[TBL] [Abstract][Full Text] [Related]
8. Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia.
Lin L; Wang W; Xiao K; Guo X; Zhou L
J Endocrinol Invest; 2023 Oct; 46(10):2095-2102. PubMed ID: 36913135
[TBL] [Abstract][Full Text] [Related]
9. Genetically supported causality between benign prostate hyperplasia and urinary bladder neoplasms: A mendelian randomization study.
Du W; Wang T; Zhang W; Xiao Y; Wang X
Front Genet; 2022; 13():1016696. PubMed ID: 36468030
[No Abstract] [Full Text] [Related]
10. The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.
Luo X; Cai B; Jin W
Metab Syndr Relat Disord; 2023 Feb; 21(1):48-56. PubMed ID: 36318808
[No Abstract] [Full Text] [Related]
11. The causal relationship of depression, anxiety, and neuroticism with main indicators of sarcopenia: A Mendelian randomization study.
Zhang Y; Song Y; Miao Y; Liu Y; Han D
Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5980. PubMed ID: 37480221
[TBL] [Abstract][Full Text] [Related]
12. Causal associations of immune cells with benign prostatic hyperplasia: insights from a Mendelian randomization study.
Li T; Zhang Y; Zhou Z; Zhang Y; Song X; Zhou X; Wan Z; Ruan Y
World J Urol; 2024 Apr; 42(1):216. PubMed ID: 38581575
[TBL] [Abstract][Full Text] [Related]
13. Genetically predicted alterations in thyroid function are associated with the risk of benign prostatic disease.
Huang Y; Chen C; Zhou W; Zhang Q; Zhao Y; He D; Ye Z; Xia P
Front Endocrinol (Lausanne); 2023; 14():1163586. PubMed ID: 37143736
[TBL] [Abstract][Full Text] [Related]
14. The relationship between circulating metabolites and prostate hyperplasia: a Mendelian randomization study.
Zhang ZC; Huang SP; Lin ZS; Chen Y; Jiang P; Yang YW; Shang CJ; Zhu M; Gao HJ
Aging Clin Exp Res; 2024 Jan; 36(1):10. PubMed ID: 38281223
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004.
Batsis JA; Mackenzie TA; Lopez-Jimenez F; Bartels SJ
Nutr Res; 2015 Dec; 35(12):1031-9. PubMed ID: 26472145
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.
Batsis JA; Mackenzie TA; Jones JD; Lopez-Jimenez F; Bartels SJ
Clin Nutr; 2016 Dec; 35(6):1472-1483. PubMed ID: 27091774
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 9 regulates metabolic profile and contributes to obesity-induced benign prostatic hyperplasia in mice.
Calmasini FB; McCarthy CG; Wenceslau CF; Priviero FBM; Antunes E; Webb RC
Pharmacol Rep; 2020 Feb; 72(1):179-187. PubMed ID: 32016843
[TBL] [Abstract][Full Text] [Related]
18. Causal associations of sarcopenia-related traits with cardiometabolic disease and Alzheimer's disease and the mediating role of insulin resistance: A Mendelian randomization study.
Ye C; Kong L; Wang Y; Zheng J; Xu M; Xu Y; Li M; Zhao Z; Lu J; Chen Y; Wang W; Ning G; Bi Y; Wang T
Aging Cell; 2023 Sep; 22(9):e13923. PubMed ID: 37403750
[TBL] [Abstract][Full Text] [Related]
19. The causal effect of sarcopenia-associated traits on brain cortical structure: A Mendelian randomization study.
Su S; Wang R; Chen Z; Zhou F
Arch Gerontol Geriatr; 2024 Mar; 118():105302. PubMed ID: 38056106
[TBL] [Abstract][Full Text] [Related]
20. Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network.
Hellwege JN; Stallings S; Torstenson ES; Carroll R; Borthwick KM; Brilliant MH; Crosslin D; Gordon A; Hripcsak G; Jarvik GP; Linneman JG; Devi P; Peissig PL; Sleiman PAM; Hakonarson H; Ritchie MD; Verma SS; Shang N; Denny JC; Roden DM; Velez Edwards DR; Edwards TL
Sci Rep; 2019 Apr; 9(1):6077. PubMed ID: 30988330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
